MXC 2.38% 41.0¢ mgc pharmaceuticals ltd

Yeh, it's a lot clearer. 3 October 2017 The Company will supply...

  1. 2,484 Posts.
    lightbulb Created with Sketch. 80
    Yeh, it's a lot clearer.

    3 October 2017
    The Company will supply four of its cannabinoids rich medicinal cannabis flower products
    (MGC MX201, MGC MX21, MGC MX11 and MGC MX120) to Lenis for wholesale distribution
    into countries including Latvia, Lithuania, Estonia, Slovenia, Croatia, Bosnia and Herzegovina,
    Serbia, Macedonia, Hungary, Romania, Bulgaria and Poland at an agreed wholesale price.
    Furthermore, MGC and Lenis will jointly market the products into Germany, Croatia, Greece
    and Italy.
    The flower products will be available in pharmacies for the treatment or relief of symptoms
    for a variety of medical conditions, such as nausea, vomiting, pain, Tourette's syndrome,
    multiple sclerosis, uncontrollable severe epilepsy, inflammatory bowel disease, Crohn's
    disease, ulcerative colitis and post-traumatic stress disorder.
 
watchlist Created with Sketch. Add MXC (ASX) to my watchlist
(20min delay)
Last
41.0¢
Change
-0.010(2.38%)
Mkt cap ! $17.97M
Open High Low Value Volume
41.0¢ 41.0¢ 40.0¢ $3.918K 9.618K

Buyers (Bids)

No. Vol. Price($)
2 13500 40.0¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 7 1
View Market Depth
Last trade - 16.10pm 28/03/2024 (20 minute delay) ?
MXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.